ArticleMolecular biomedicine2025

Targeting tumor-infiltrating regulatory T cells: combining CD47 and PD-L1 inhibition via a novel aptamer-siRNA chimera.

Yu Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.